The U.S. Supreme Court on Tuesday turned away a patent dispute between labeling company Avery Dennison Corp and ADASA Inc that would have given it a chance to clarify a standard that critics have said has sown confusion about what inventions can be legally protected and led to cancellations of valid patents.
Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.
Alphabet's Google received a mixed ruling on Thursday from a San Francisco federal judge in a patent lawsuit brought by Sonos Inc over wireless audio technology, failing to invalidate all of the patents before a trial but narrowing Sonos' claims.
Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson's disease drug Neupro, clearing an obstacle for Teva's Actavis Laboratories UT Inc and Viatris' Mylan Technologies Inc to sell generic versions of the drug.
Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc and its German partner BioNTech SE in a New Jersey district court, claiming their mRNA COVID-19 vaccines infringe five of Arbutus' patents.